BioScience Health Innovations, Inc.
BHIC
$6.40
$2.1048.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2,554.55% | -101.92% | 7.24% | 4,168.00% | -82.21% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | 158.55% | -92.07% | -75.33% | -63.35% | -1,407.50% |
| Cash from Operations | 70.42% | -219.44% | -13.19% | 752.68% | -196.36% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | 46.33% | -57.89% | -171.43% |
| Cash from Investing | -- | 100.00% | 46.33% | -57.89% | -171.43% |
| Total Debt Issued | -39.45% | 28.48% | 36.06% | 118.25% | -1.53% |
| Total Debt Repaid | -16.47% | -6.25% | -53.26% | -59.88% | -27.94% |
| Issuance of Common Stock | -- | -- | -- | -- | 264.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -302.77% | 8,495.24% | -96.89% | -83.07% | 176.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.44% | -159.02% | -25.89% | 11.08% | 73.96% |